Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery.

NCT04711837 is registered in ClinicalTrials.gov with Haisco-USA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04711837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04711837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery.
Lead sponsor
Haisco-USA Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 11, 2021
Completion date
April 20, 2022
Enrollment
255 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia